Last reviewed 2026-04-19 · How we verify

PF-06873600 (pf-06873600)

Pfizer Inc. · discontinued

PF-06873600 (generic name: pf-06873600) is a PF-06873600 tablet for oral dosing drug developed by Pfizer Inc.. It is currently in discontinued development.

PF-06873600 tablet for oral dosing

PF-06873600 is a discontinued investigational drug developed by Pfizer Inc. The specific mechanism of action and intended indications for PF-06873600 are not publicly disclosed. As the drug is no longer in development, further information on its properties and potential uses is limited.

At a glance

Generic name	pf-06873600
Sponsor	Pfizer Inc.
Drug class	PF-06873600 tablet for oral dosing
Therapeutic area	Oncology
Phase	discontinued

Approved indications

No approved indications tracked.

Pipeline indications

HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer — discontinued

Common side effects

No common side effects on file.

Key clinical trials

A Study of PF-06873600 in People With Cancer (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PF-06873600 CI brief — competitive landscape report
PF-06873600 updates RSS · CI watch RSS
Pfizer Inc. portfolio CI

Frequently asked questions about PF-06873600

What is PF-06873600?

PF-06873600 (pf-06873600) is a PF-06873600 tablet for oral dosing drug developed by Pfizer Inc..

How does PF-06873600 work?

PF-06873600 tablet for oral dosing

Who makes PF-06873600?

PF-06873600 is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).

What is the generic name of PF-06873600?

pf-06873600 is the generic (nonproprietary) name of PF-06873600.

What drug class is PF-06873600 in?

PF-06873600 belongs to the PF-06873600 tablet for oral dosing class. See all PF-06873600 tablet for oral dosing drugs at /class/pf-06873600-tablet-for-oral-dosing.

What development phase is PF-06873600 in?

PF-06873600 is in discontinued.

Drug class: All PF-06873600 tablet for oral dosing drugs
Manufacturer: Pfizer Inc. — full pipeline
Therapeutic area: All drugs in Oncology

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing